Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Graft Versus Host Disease in Skin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03505853
What this trial is testing

Investigate the Interaction Between Givosiran and a 5-probe Drug Cocktail in Patients With Acute Intermittent Porphyria (AIP)

Who this might be right for
Acute Intermittent Porphyria (AIP)Acute Hepatic Porphyria (AHP)Porphyria, Acute Intermittent+1 more
Alnylam Pharmaceuticals 10
Testing effectiveness (Phase 2)Study completedNCT00110045
What this trial is testing

Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant

Who this might be right for
Cancer
European Organisation for Research and Treatment of Cancer - EORTC 171
Large-scale testing (Phase 3)Study completedNCT02066402
What this trial is testing

Efficacy and Safety of Intravenous to Oral 6-Day Tedizolid Phosphate vs. Intravenous to Oral 10-Day Linezolid in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)

Who this might be right for
Bacterial Infections
Bayer 598
Early research (Phase 1)Study completedNCT04723602
What this trial is testing

Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults

Who this might be right for
Ebola Virus DiseaseMarburg Virus Disease
Albert B. Sabin Vaccine Institute 32
Not applicableLooking for participantsNCT00991094
What this trial is testing

Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy

Who this might be right for
Breast CarcinomaEsophageal CarcinomaGenitourinary System Carcinoma+6 more
M.D. Anderson Cancer Center 5,000
Not applicableStudy completedNCT00723671
What this trial is testing

Magnetic Resonance Spectroscopy, Perfusion and Diffusion Tensor Imaging in Neuropsychiatric Lupus

Who this might be right for
Systemic Lupus ErythematosusFibromyalgiaAcute Neuropsychiatric Lupus
University of Michigan 66
Not applicableWithdrawnNCT00378781
What this trial is testing

Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection

Who this might be right for
Cancer
M.D. Anderson Cancer Center
Not applicableStudy completedNCT03924011
What this trial is testing

Photobiomodulation Therapy for the Prevention of Acute Radiodermatitis in Breast Cancer Patients Undergoing Radiotherapy

Who this might be right for
RadiodermatitisBreast Cancer
Hasselt University 71
Not applicableUnknownNCT03985475
What this trial is testing

Identification of the Cutaneous Microbiota in Patients With Cutaneous Infection (MICROBIOTA)

Who this might be right for
Skin Infections
Assistance Publique Hopitaux De Marseille 100
Testing effectiveness (Phase 2)Study completedNCT00937131
What this trial is testing

The Use of Rituximab in Acute Thrombotic Thrombocytopenic Purpura (TTP)

Who this might be right for
Thrombotic Thrombocytopenic Purpura (TTP)
University College, London 40
Testing effectiveness (Phase 2)Study completedNCT01209078
What this trial is testing

GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection

Who this might be right for
Skin Infections, Bacterial
GlaxoSmithKline 84
Very early researchActive Not RecruitingNCT06765876
What this trial is testing

CART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: A Dose Escalation Phase I Trial

Who this might be right for
Leukemia, Myeloid, Acute(AML)Precursor Cell Lymphoblastic Leukemia-LymphomaMyelodysplastic Syndromes (MDS)+1 more
Institute of Hematology and Blood Transfusion, Czech Republic 18
Large-scale testing (Phase 3)Study completedNCT00855920
What this trial is testing

Study Utilizing Rilonacept in Gout Exacerbations

Who this might be right for
Acute Gout Flare
Regeneron Pharmaceuticals 225
Not applicableEnded earlyNCT03547297
What this trial is testing

INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP

Who this might be right for
Acute Hepatic PorphyriaHepatic PorphyriasAcute Intermittent Porphyria (AIP)+4 more
Alnylam Pharmaceuticals 212
Not applicableEnded earlyNCT01619410
What this trial is testing

Asymptomatic Colonization With S. Aureus After Therapy With Linezolid or Clindamycin for Acute Skin Infections

Who this might be right for
Skin Diseases, BacterialAbscess
University of Chicago 25
Not applicableNot Yet RecruitingNCT07246720
What this trial is testing

IPP-PSP Block vs. SPSIPB in Breast Surgery

Who this might be right for
Postoperative Acute PainBreast CancerRegional Anesthesia
Zonguldak Bulent Ecevit University 70
Not applicableLooking for participantsNCT05665920
What this trial is testing

Efficacy and Safety of Ultra_HYPofractionated RadiotHerapy in Women With BrEast CaNcer Receiving Regional Nodal Radiation vs Nodal Moderate Hypofractionated Radiotherapy

Who this might be right for
Malignant Breast Neoplasm
Instituto Brasileiro de Controle do Cancer 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT03386513
What this trial is testing

Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN

Who this might be right for
Blastic Plasmacytoid Dendritic Cell NeoplasmMyeloproliferative Neoplasm
AbbVie 179
Large-scale testing (Phase 3)Study completedNCT00168103
What this trial is testing

Human C1 Esterase Inhibitor (C1-INH) in Subjects With Acute Abdominal or Facial Hereditary Angioedema (HAE) Attacks

Who this might be right for
Hereditary Angioedema
CSL Behring 126
Not applicableUnknownNCT04530461
What this trial is testing

Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases

Who this might be right for
SARS-CoV InfectionSystemic DiseaseSystemic Lupus Erythematosus+6 more
faida agili 200
Next Page